Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Miles

Showing results (741-750 of 824) with videos related to

Pageof 83
Sort By:
Science Translational Medicine|December 13, 2023
Short-course combination treatment for experimental chronic Chagas diseaseSilvia González, Richard J Wall, John Thomas, et al.
Nature Immunology|March 14, 2018
T cell autoreactivity directed toward CD1c itself rather than toward carried self lipidsKwok S Wun, Josephine F Reijneveld, Tan-Yun Cheng, et al.
British Journal of Pharmacology|July 12, 2022
The structural conformation of the tachykinin domain drives the anti-tumoural activity of an octopus peptide in melanoma BRAF<sup>V600E</sup>Javier Moral-Sanz, Manuel A Fernandez-Rojo, Gonzalo Colmenarejo, et al.
Cell|April 29, 2014
Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressorsPatrick Kemmeren, Katrin Sameith, Loes A L van de Pasch, et al.
Nature|July 27, 2018
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasisSusan Wyllie, Michael Thomas, Stephen Patterson, et al.
Journal of Medicinal Chemistry|August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruziStephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
BMC Psychiatry|November 15, 2024
The California collaborative network to promote data driven care and improve outcomes in early psychosis (EPI-CAL) project: rationale, background, design and methodologyValerie L Tryon, Kathleen E Nye, Mark Savill, et al.
ACS Infectious Diseases|December 7, 2019
Setting Our Sights on Infectious DiseasesManu De Rycker, David Horn, Bree Aldridge, et al.
Journal of Medicinal Chemistry|July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome InhibitorsMichael G Thomas, Kate McGonagle, Paul Rowland, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Pageof 83

Showing results (741-750 of 824) with videos related to

Sort By:
Pageof 83
Science Translational Medicine|December 13, 2023
Short-course combination treatment for experimental chronic Chagas diseaseSilvia González, Richard J Wall, John Thomas, et al.
Nature Immunology|March 14, 2018
T cell autoreactivity directed toward CD1c itself rather than toward carried self lipidsKwok S Wun, Josephine F Reijneveld, Tan-Yun Cheng, et al.
British Journal of Pharmacology|July 12, 2022
The structural conformation of the tachykinin domain drives the anti-tumoural activity of an octopus peptide in melanoma BRAF<sup>V600E</sup>Javier Moral-Sanz, Manuel A Fernandez-Rojo, Gonzalo Colmenarejo, et al.
Cell|April 29, 2014
Large-scale genetic perturbations reveal regulatory networks and an abundance of gene-specific repressorsPatrick Kemmeren, Katrin Sameith, Loes A L van de Pasch, et al.
Nature|July 27, 2018
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasisSusan Wyllie, Michael Thomas, Stephen Patterson, et al.
Journal of Medicinal Chemistry|August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruziStephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
BMC Psychiatry|November 15, 2024
The California collaborative network to promote data driven care and improve outcomes in early psychosis (EPI-CAL) project: rationale, background, design and methodologyValerie L Tryon, Kathleen E Nye, Mark Savill, et al.
ACS Infectious Diseases|December 7, 2019
Setting Our Sights on Infectious DiseasesManu De Rycker, David Horn, Bree Aldridge, et al.
Journal of Medicinal Chemistry|July 28, 2023
Structure-Guided Design and Synthesis of a Pyridazinone Series of <i>Trypanosoma cruzi</i> Proteasome InhibitorsMichael G Thomas, Kate McGonagle, Paul Rowland, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Pageof 83